Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1266 issues

How Long Does It Take to Get Abecma (idecabtagene vicleucel) Approved by Blue Cross Blue Shield in Washington? Complete Timeline & Appeals Guide

Answer Box: Fastest Path to Abecma Approval Blue Cross Blue Shield plans in Washington (Premera, Regence) typically process Abecma prior authorization in 1-5 business days for standard requests, 72 hours for urgent cases. Submit complete documentation including ≥2 prior therapy failures (IMiD, proteasome inhibitor, anti-CD38), recent labs, and treatment at
6 min read

How to Get Revlimid (Lenalidomide) Covered by Blue Cross Blue Shield Michigan: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Getting Revlimid Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Revlimid (lenalidomide) through their Oncology Value Management program. The fastest path to approval involves three key steps: (1) Ensure REMS compliance documentation is complete, (2) Submit PA request via OncoHealth with complete
5 min read

How to Get Cystadane (betaine anhydrous) Covered by Blue Cross Blue Shield of Texas: Prior Authorization, Appeals, and State Protections

Answer Box: Getting Cystadane Covered in Texas Blue Cross Blue Shield of Texas requires prior authorization for Cystadane (betaine anhydrous) for homocystinuria. Submit through Carelon Medical Benefits Management at 1-866-455-8415 or via Availity with diagnosis confirmation, lab results showing elevated homocysteine (>50 µmol/L), and documentation of vitamin therapy
6 min read

Get Humira (Adalimumab) Approved by Blue Cross Blue Shield North Carolina: Complete Forms, Appeals & Contact Guide

Answer Box: Getting Humira Approved by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Humira (adalimumab) with step therapy through preferred biosimilars first. Submit PA via the Availity Provider Portal or call 800-672-7897. Include clinical documentation of biosimilar failures, diagnosis codes, and medical necessity.
6 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Enhertu Covered by BCBS in New York Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Blue Cross Blue Shield plans in New York for HER2-positive breast cancer, NSCLC, and gastric cancer. Key requirements include documented HER2 status (IHC 3+ or ISH amplified), prior trastuzumab-based therapy failure, and NCCN
6 min read

How to Get Zolgensma (onasemnogene abeparvovec-xioi) Covered by Blue Cross Blue Shield in California: Prior Authorization Guide, Appeals Process, and Success Strategies

Answer Box: Fast Track to Zolgensma Coverage Blue Shield of California requires prior authorization for Zolgensma with specific clinical criteria: confirmed SMA diagnosis via genetic testing, age under 2 years, ≤3 SMN2 gene copies, and no advanced disease. Submit through AuthAccel portal with genetic documentation. If denied, file internal appeal
5 min read